NACDS Foundation raises $1.8 million for research, education

Results from the CATALYST trial showed patients who received mifepristone had a mean HbA1c reduction of 1.47%,

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.

Pharmacy technicians must be recognized and empowered as essential, long-term professionals to improve workplace well-being, patient care, and pharmacy success.

Amid the continuously evolving role of pharmacists in today’s health care landscape, independent owners like Amina Abubakar, PharmD, AAHIVP, are advancing the profession through innovation.

From 2019 to 2024, GLP-1 prescriptions among pediatric patients with type 2 diabetes increased from 12.3% to 60.9%.